These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 9589247)

  • 81. Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus.
    Recasens M; Aguilera E; Morínigo R; Casamitjana R; Nicoletti F; Gomis R; Conget I
    Diabetes Res Clin Pract; 2003 Jun; 60(3):153-9. PubMed ID: 12757987
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Short acting insulin analogues for treating diabetic patients with CSII (continuous subcutaneous insulin infusion)].
    Jermendy G
    Orv Hetil; 2006 Nov; 147(46):2223-6. PubMed ID: 17396394
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes.
    Rami B; Schober E
    Eur J Pediatr; 1997 Nov; 156(11):838-40. PubMed ID: 9392394
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.
    Warren M; Bode B; Cho JI; Liu R; Tobian J; Hardy T; Chigutsa F; Phillip M; Horowitz B; Ignaut D
    Diabetes Obes Metab; 2021 Jul; 23(7):1552-1561. PubMed ID: 33687783
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Diabet Med; 2010 Apr; 27(4):480-4. PubMed ID: 20536523
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus.
    Czock D; Aisenpreis U; Rasche FM; Jehle PM
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):492-7. PubMed ID: 14703957
    [TBL] [Abstract][Full Text] [Related]  

  • 88. U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.
    Scheen AJ; Henrivaux P; Jandrain B; Lefèbvre PJ
    Diabetes Care; 1987; 10(6):707-11. PubMed ID: 3322727
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump.
    Thrasher J; Surks H; Nowotny I; Pierre S; Rotthaeuser B; Wernicke-Panten K; Garg S
    J Diabetes Sci Technol; 2018 May; 12(3):680-686. PubMed ID: 29359575
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus.
    Tupola S; Komulainen J; Jääskeläinen J; Sipilä I
    Diabet Med; 2001 Aug; 18(8):654-8. PubMed ID: 11553203
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Glycemic response during exercise after administration of insulin lispro compared with that after administration of regular human insulin.
    Yamakita T; Ishii T; Yamagami K; Yamamoto T; Miyamoto M; Hosoi M; Yoshioka K; Sato T; Onishi S; Tanaka S; Fujii S
    Diabetes Res Clin Pract; 2002 Jul; 57(1):17-22. PubMed ID: 12007726
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria.
    Berg TJ; Nourooz-Zadeh J; Wolff SP; Tritschler HJ; Bangstad HJ; Hanssen KF
    Diabetes Care; 1998 Aug; 21(8):1295-300. PubMed ID: 9702436
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efficacy of Humalog injections before an afternoon meal and their acceptance by children and adolescents with type 1 diabetes.
    Martin D; Licha-Müntz G; Grasset E; Grenèche MO; Nouet D; François L; Legrand C; Polak M; Augendre-Ferrante B; Tubiana-Rufi N; Robert JJ
    Diabet Med; 2002 Dec; 19(12):1026-31. PubMed ID: 12647845
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.
    Kolterman OG; Schwartz S; Corder C; Levy B; Klaff L; Peterson J; Gottlieb A
    Diabetologia; 1996 Apr; 39(4):492-9. PubMed ID: 8778001
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women.
    Mecacci F; Carignani L; Cioni R; Bartoli E; Parretti E; La Torre P; Scarselli G; Mello G
    Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):19-24. PubMed ID: 14557006
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.
    Fineberg NS; Fineberg SE; Anderson JH; Birkett MA; Gibson RG; Hufferd S
    Diabetes; 1996 Dec; 45(12):1750-4. PubMed ID: 8922361
    [TBL] [Abstract][Full Text] [Related]  

  • 98. What is the role of between meal snacks with intensive basal bolus regimens using preprandial lispro?
    Kong N; Ryder RE
    Diabet Med; 1999 Apr; 16(4):325-31. PubMed ID: 10220207
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin.
    ter Braak EW; Woodworth JR; Bianchi R; Cerimele B; Erkelens DW; Thijssen JH; Kurtz D
    Diabetes Care; 1996 Dec; 19(12):1437-40. PubMed ID: 8941480
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure.
    Berthe E; Lireux B; Coffin C; Goulet-Salmon B; Houlbert D; Boutreux S; Fradin S; Reznik Y
    Horm Metab Res; 2007 Mar; 39(3):224-9. PubMed ID: 17373639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.